SPIA
NRIX icon

Steward Partners Investment Advisory’s Nurix Therapeutics NRIX Stock Holding History

Steward Partners Investment Advisory’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Hold
438
– – ﹤0.01% 3709
2026
Q1 		$6.79K Hold
438
– – ﹤0.01% 3708
2025
Q4 		$8.31K Hold
438
– – ﹤0.01% 3512
2025
Q3 		$4.05K Buy
+438
New +$4.55K ﹤0.01% 3719
2024
Q4 		– Sell
-4,050
Closed -$91K – 4051
2024
Q3 		$91K Buy
+4,050
New +$91.7K ﹤0.01% 1924

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Steward Partners Investment Advisory's NRIX Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Nurix Therapeutics (NRIX) position steady in Q2 2026 at 438 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3709.

Steward Partners Investment Advisory first reported a position in NRIX in Q3 2024 and has held it in 5 quarters since. The position peaked at $91K in Q3 2024. 174 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Steward Partners Investment Advisory held 438 shares of Nurix Therapeutics worth $10.6K as of Q2 2026.
  • Steward Partners Investment Advisory left its Nurix Therapeutics share count unchanged in Q2 2026.
  • Nurix Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3709 holding.
  • Steward Partners Investment Advisory first reported a position in Nurix Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • Steward Partners Investment Advisory's Nurix Therapeutics position peaked at $91K in Q3 2024.
  • 174 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.